2024-04-01 LIDR Meeting Notes

Date

Apr 1, 2024

Attendees

(Bolded indicates presence at meeting)

Name	Organization

Name	Organization
Hung Luu	Children’s
Riki Merrick	Vernetzt, APHL
Andrea Pitkus	UW
Pam Banning	3M - Solventum
Xavier Gansel	Biomerieux
Amy McCormick	Epic
Dan Rutz	Epic
Rob Rae	CAP
Rob Hausam	Hausam Consulting
Sandy Jones	CDC
Stan Huff	Graphite
Ed Heierman	Abbott / IICC
Andrew Quinn
Laurent Lardin	Biomerieux
Anthony Killeen	UMN
Craig Collom
Marti Velezis	Sonrisa / FDA
Walter Sujansky	FDA
Susan Downer	JMC
Ralf Herzog	Roche
Cornelia Felder	Roche
Daniel Golson	JMC
Andrea Prada	JMC
Maria Sagat	CAP
Raja Cholan	FDA
Russ Ott	FDA
Akila Namasivayam	FDA
Desiree Mustaquim	CDC
John Spinosa	Lantana

Agenda and Notes

Topic	Notes

Topic	Notes
Reviewing minutes from the last call - Action Item Follow up	Pull out the definitions from LIVD for test kit and equipment and put here: SHIELD Glossary Review operational definition of “equivalence” Outreach to Dr. DeBaca Hung will check for more info and maybe see, if she could participate in SHIELD Keep updating the googlesheet: Potassium LIVD data Shared Reportable Conditions LIVD google sheet for crowdsourcing with CSTE - added sign up sheet for PHAs to specific conditions and see how that develops Have LIVD File Repository Requirements Have draft budget (for setting up a web-based database and yearly maintenance): https://aphlinformatics.atlassian.net/wiki/download/attachments/915407143/LIDR - Budget.xlsx?api=v2 Review LIDR Use Cases and sign up to lead one of these - prioritize these use cases, so that we can finalize the requirements for the first phase of LIDR Define next steps to migrate existing LIVD files into FHIR LIVD catalog format and find a FHIR server to host Riki to see, if Marti can share the LIDR categorical data to instance data mapping for each element
Call Schedule	send OOO via chat or email
LIDR Elements Discussion	Not today
Review LIDR White Paper	Discussing the TINKAR work - we need to make sure all understand the differences between LIDR, lab compendiums and instance data Reviewing the comments in the LIDR paper: Raja added a sentence - Xavier to review to see, if that reolves his comments DIscussion about the LOINC model statement - the LOINC model, like no other terminology currently can represent the same tests the same way - due to mapping interpretations and also to the level of granualrity that the LOINC model can accommodate - use ideally or initially designed Attributes not provided by the IVD vendors in LIVD - like calculations or challenge test information - this may need to be curated by the LIDR team - add more examples to the section Will start with “Roadmap for LIDR - Riki” review next week - goal of this section is to take the requirements Stan wrote up and put them in temporal order to create something useful right away and then expand on that Also need to populate the “How to get involved” section - RIki wil l draft a few sentences - don't think it needs to be more than that.
ACTION ITEMS	Please see the action items at top of this page - Next deliverable is White paper draft by end of this month
Next call	Monday 4/8/2024 9 - 10 AM ET
Adjourned	9:55 AM ET

Action items

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.